CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 54 filers reported holding CABALETTA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,790,514 | +101158.0% | 371,070 | -35.1% | 0.00% | -33.3% |
| Q1 2023 | $4,731 | +45.7% | 572,119 | +62.9% | 0.00% | +50.0% |
| Q4 2022 | $3,248 | -97.8% | 351,125 | +52.3% | 0.00% | – |
| Q3 2022 | $150,000 | -40.7% | 230,553 | -3.2% | 0.00% | – |
| Q2 2022 | $253,000 | -65.5% | 238,236 | -34.0% | 0.00% | – |
| Q1 2022 | $733,000 | +36.0% | 361,001 | +154.0% | 0.00% | – |
| Q4 2021 | $539,000 | -63.6% | 142,137 | +16.9% | 0.00% | -100.0% |
| Q3 2021 | $1,479,000 | -82.6% | 121,624 | -87.7% | 0.00% | -80.0% |
| Q2 2021 | $8,517,000 | -21.8% | 990,330 | +1.0% | 0.01% | -28.6% |
| Q1 2021 | $10,889,000 | +44.2% | 980,913 | +62.1% | 0.01% | +40.0% |
| Q4 2020 | $7,553,000 | +15.8% | 605,245 | +0.6% | 0.01% | -37.5% |
| Q3 2020 | $6,524,000 | -7.3% | 601,830 | -4.8% | 0.01% | -20.0% |
| Q2 2020 | $7,039,000 | +145.4% | 631,904 | +60.9% | 0.01% | +66.7% |
| Q1 2020 | $2,868,000 | -14.4% | 392,815 | +63.7% | 0.01% | +50.0% |
| Q4 2019 | $3,352,000 | – | 239,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |